TISPX
Price
$70.14
Change
+$0.55 (+0.79%)
Updated
Aug 8 closing price
Net Assets
N/A
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

TISPX vs VSTSX

Header iconTISPX vs VSTSX Comparison
Open Charts TISPX vs VSTSXBanner chart's image
Nuveen S&P 500 Index R6
Price$70.14
Change+$0.55 (+0.79%)
VolumeN/A
Net AssetsN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
TISPX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TISPX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TISPX is a StrongBuy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX (1.20) and TISPX (1.15) have matching dividends . TISPX was incepted earlier than VSTSX: TISPX (23 years) vs VSTSX (9 years). TISPX (0.05) is less costly to investors than VSTSX (0.01). TISPX is a more actively managed with annual turnover of: 3.00 vs. VSTSX (2.00). TISPX has a lower initial minimum investment than VSTSX: TISPX (1000000) vs VSTSX (5000000000). TISPX annual gain was more profitable for investors over the last year : 21.35 vs. VSTSX (19.70). TISPX return over 5 years is better than : 99.68 vs. VSTSX (85.11).
TISPXVSTSXTISPX / VSTSX
Total Expense Ratio0.050.01500%
Annual Report Gross Expense Ratio0.050.01500%
Fund Existence23 years9 years-
Gain YTD9.4408.088117%
Front LoadN/AN/A-
Min. Initial Investment100000050000000000%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A1.91T-
Annual Yield % from dividends1.151.2096%
Returns for 1 year21.3519.70108%
Returns for 3 years58.5352.05112%
Returns for 5 years99.6885.11117%
Returns for 10 years219.91N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited